Goldman Sachs Remains Bullish on AbbVie (ABBV) After Meeting with Management
Tweet Send to a Friend
Goldman Sachs reiterated a Buy rating and $135.00 price target on Abbvie (NYSE: ABBV) after meeting with ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
